NATIONAL KIDNEY FOUNDATION for NATIONAL KIDNEY FOUNDATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2027 Appropriations for organ donation and transplantation activities (HRSA). FY 2027 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2027 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2027 Appropriations for Dept. of Defense Congressionally Directed Medical Research Program. FY 2027 Appropriations for Indian Health Service.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN DREW | — |
| TROY ZIMMERMAN | — |
Health Issues HCR
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN DREW | — |
| MIRIAM ELIZABETH GODWIN | — |
| TROY ZIMMERMAN | — |
Medicare/Medicaid MMM
Initiatives to expand access to home dialysis. H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN DREW | — |
| MIRIAM ELIZABETH GODWIN | — |
| TROY ZIMMERMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.